Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Albireo Pharma Inc. (ALBO)

30.07   -0.51 (-1.67%) 03-21 16:00
Open: 30.3 Pre. Close: 30.58
High: 30.985 Low: 29.79
Volume: 24,048 Market Cap: 362M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 31.029 - 31.18 31.18 - 31.329
Low: 29.352 - 29.539 29.539 - 29.722
Close: 29.723 - 30.02 30.02 - 30.313

Technical analysis

as of: 2019-03-21 4:25:55 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 38.11     One year: 44.51
Support: Support1: 27.91    Support2: 24.99
Resistance: Resistance1: 32.63    Resistance2: 38.11
Pivot: 30.43
Moving Average: MA(5): 30.75     MA(20): 29.54
MA(100): 26.00     MA(250): 29.68
MACD: MACD(12,26): 1.14     Signal(9): 1.24
Stochastic oscillator: %K(14,3): 58.25     %D(3): 67.96
RSI: RSI(14): 55.87
52-week: High: 37.95  Low: 19.10  Change(%): -11.5
Average Vol(K): 3-Month: 3691  10-Days: 3456

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ALBO has closed above bottom band by 40.0%. Bollinger Bands are 26.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 07 Mar 2019 22:10:59 Z
Albireo Pharma, Inc. (ALBO) Q4 2018 Earnings Conference Call Transcript

Mon, 12 Nov 2018 21:16:40 Z
Pre-Market Earnings Report for November 13, 2018 : HD, TSN, AAP, ARMK, CAE, EYE, GDS, EPC, OPTN, MGIC, ALBO, BZH

Wed, 16 May 2018 20:16:51 Z
Pre-Market Earnings Report for May 17, 2018 : WMT, PLCE, TGP, TOO, KEM, JCP, MANU, TK, ECC, ALBO, TNK, VBLT

Mon, 29 Jan 2018 13:30:41 Z
3 Hot Insider Biotech Stocks You Need to Know

Thu, 21 Dec 2017 15:14:12 Z
3 'Strong Buy' Biotechs That Can Double in 2018

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12.03
Shares Float (M) 8.16
% Held by Insiders 32.40
% Held by Institutions 91.70
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -3.880
EPS Est. Current Year -3.640
EPS Est. Next Year -3.440
EPS Est. Next Quarter -0.910
Forward EPS -3.709
Book Value (p.s.) 2.980
PEG Ratio
Profit Margin
Operating Margin -297.41
Return on Assets (ttm) -35.7
Return on Equity (ttm) -49.1
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -26.80
Levered Free Cash Flow (M) -18.26

Stock Valuations

P/E -7.75
P/E Growth Ratio -0.02
P/BV 10.09
P/S 331873472.00
P/CF -13.49

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2016-11-04
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.